LINCOLN, Neb., Aug. 30, 2017 -- National Research Corporation (NASDAQ:NRCIA) (NASDAQ:NRCIB) Board of Directors member Gail L. Warden announced his retirement from the board effective today.
Mr. Warden has served as a director of National Research since January 2005. He is currently President Emeritus of Detroit-based Henry Ford Health System where he served as President and Chief Executive Officer from 1988 until 2003. Prior to this role, Mr. Warden served as President and Chief Executive Officer of Group Health Cooperative of Puget Sound, as well as Executive Vice President of the American Hospital Association. Mr. Warden serves as Chairman to several national healthcare committees and as a board member to many other healthcare related committees and institutions.
Michael D. Hays, chief executive officer of National Research Corporation said, “I want to thank Gail for his fine service for over 12 years. The time he served on our Board was marked by unsurpassed excellence. He has been an inspiration to us all.”
Lead Board Director, John N. Nunnelly, commented, “Gail’s extensive experience in the healthcare industry and the many leadership roles he has held with healthcare enterprises made him a valuable member of our board. He will be missed.”
For more than 36 years, National Research Corporation has been a leading provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers and other healthcare organizations in the United States and Canada. The Company’s solutions enable its clients to understand the voice of the customer with greater clarity, immediacy and depth.
Contact: Kevin Karas Chief Financial Officer 402-475-2525


Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
Apple Turns 50: From Garage Startup to AI Crossroads
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit 



